Weil, Gotshal & Manges LLP continues to be a go-to firm on complex, cross-border merger reviews, with the team regularly instructed on transactions that attract close scrutiny from US agencies and parallel review overseas. Backed by deep former-agency expertise and a proven track record in steering deals through second requests and remedy negotiations, the team remains a regular fixture on transactions in the pharmaceuticals and chemicals sectors. Leadership of the Washington DC practice sits with Brianne Kucerik, Michael Moiseyev and Jeffrey Perry. Kucerik advises on merger review across sectors including pharmaceuticals and industrials, while Moiseyev and Perry draw on senior FTC experience when guiding clients through transactions facing heightened scrutiny. Jeff White is regularly involved on multi-jurisdictional deals alongside high-stakes antitrust litigation. Megan Granger advises on merger review in the technology, retail and energy sectors, often coordinating advocacy before US and overseas agencies, while Elizabeth Ross handles complex US and global regulatory approvals and antitrust investigations across energy, pharmaceuticals, private equity and asset management.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘John Scribner is incredible. He is smart, humble, and client focused. It is a genuine joy to work with.’
  • ‘I've worked with antitrust teams from every major law firm, and I consider Weil to be the best overall. I find many antitrust teams value their relationship with government agencies more than they do their clients. This is not the case with Weil.'
  • ‘Megan Granger and team represented my company in a large transaction with multiple jurisdiction issues. The Weil team was pragmatic, straight forward and direct. They partnered with local counsel well and communicated in a time sensitive way.’
  • ‘Megan Granger in particular took lead of our matter with Jeff Perry supporting from the US. Megan was very responsive even with time difference and would be flexible when I asked for different styles of work product and presentations.’
  • 'They are client-focused, practical, and results-oriented. The Weil team are quick studies, quickly learning complex and technical scientific information. We have always been satisfied with the outcome.’

Key clients

  • ChampionX Corporation
  • Giant Eagle, Inc.
  • Groupe Lactalis S.A.
  • The Home Depot
  • Meta Platforms, Inc.
  • Microsoft Corporation
  • Sanofi
  • Brookfield Asset Management
  • Johnson & Johnson
  • Hologic, Inc.
  • L’Oreal
  • Foundation Building Materials and PE sponsors (American Securities LLC and Clayton Dubilier & Rice, LLC)

Work highlights

Represented ChampionX Corporation in its acquisition by SLB, the world’s second largest oilfield services provider, for ~$7.75 billion.
Advised Giant Eagle, Inc. in its $1.6 billion sale of GetGo Café + Market Stores, to Alimentation Couche-Tard, Inc. (Canada).
Representing Meta Platforms, Inc., in numerous transactions that are essential to Meta’s AI strategy, including its $14.3B investment in Scale AI.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Next Generation Partners

Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Leading associates

Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.

Practice head

Brianne Kucerik; Michael Moiseyev; Jeffrey Perry

Other key lawyers

Jeff White; John Scribner; Megan Granger; Elizabeth Ross